Nuvaxovid™ COVID-19 vaccine is the first protein-based option for adolescents aged 12 through 17 in Europe GAITHERSBURG, Md., July 5, 2022 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious…
Related Posts
U.S. Tsubaki Acquires ATRA-FLEX® to Expand its North American Manufacturing Capabilities for Premium Industrial Couplings
WHEELING, Ill., Aug. 31, 2022 /PRNewswire/ — U.S. Tsubaki Power Transmission, LLC (U.S. Tsubaki) is excited to announce the purchase…
XAG Drone Supports Cacao Farm to Fight Diseases during Rainy Spells
GUAYAQUIL, Ecuador, July 13, 2022 /PRNewswire/ — To facilitate sustainable, local cacao production for the finest chocolate, XAG agricultural drone…
Entergy Texas declares quarterly dividend on preferred stock
THE WOODLANDS, Texas, June 21, 2022 /PRNewswire/ — The Entergy Texas, Inc. board of directors has declared a quarterly dividend…
